Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

Clinical trial NCT00395421 · COMPLETED

Trial details

NCT number: NCT00395421
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2006-10-01
Primary completion: 2008-06-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.